The results suggest that LC-MUFAs may ameliorate obesity-related metabolic dysfunction partly through increased expression of Pparg as well as its target genes, and decreased inflammatory marker expression in white adipose tissue. Here, PPARG is linked to obesity due to melanocortin 4 receptor deficiency.